Medical News

RSS

Meridian Bioscience revises fiscal 2010 guidance, expects net sales between $145M and $153M

Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it is revising downward its previous sales and earnings guidance for the fiscal year ending September 30, 2010. This action is being taken as a result of weaker than expected operating results for the second quarter ending March 31, 2010, based on preliminary results to date. Separately, Meridian announced that it will file a 510(k) for FDA marketing clearance next week in connection with its illumigene™ C. difficile product.

17 Mar 2010

SBRT may improve survival rates for lung-cancer patients: Study

A radiation therapy that uses multiple radiation beams to target tumors precisely has been shown to eliminate the primary tumor and ultimately may improve survival rates for lung-cancer patients unable to undergo surgery, according to UT Southwestern Medical Center physicians who led a national clinical trial of the treatment.

17 Mar 2010

China Sky One Medical's 2009 fourth-quarter total revenues up 15.0%

China Sky One Medical, Inc., a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced financial results for the fourth quarter and fiscal year ended December 31, 2009. The Company also announced its earnings guidance for full year 2010.

17 Mar 2010

IRIS International announces the launch of new and improved corporate website

IRIS International, Inc., a leading manufacturer of urinalysis systems and consumables for use in hospitals and commercial laboratories worldwide, announced today the launch of its new and improved corporate website at www.proiris.com, featuring a newly designed homepage and enhanced navigation tools with access to the latest company information.

17 Mar 2010

StockPreacher.com: ACAD reports net loss of $8.7M for fourth-quarter of 2009

StockPreacher.com announces an investment report featuring ACADIA Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

17 Mar 2010

Full Medicare coverage for IVF: CFAS felicitates Quebec government

The Canadian Fertility and Andrology Society (CFAS) congratulates Premier Jean Charest and his Government on their announcement of full Medicare coverage for in-vitro fertilization treatments in Quebec.

17 Mar 2010

Renhuang Pharmaceuticals' net income for first-quarter of 2010 increases 17.8%

Renhuang Pharmaceuticals, Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines, today announced its financial results for the first quarter ended January 31, 2010.

17 Mar 2010

Research confirms benefits of PET scan in early detection of Alzheimer's disease

Westside Medical Associates of Los Angeles and Westside Medical Imaging (WMI) of Beverly Hills announce the benefit of early positron emission tomography (PET) scanning to identify Alzheimer's in its early more treatable phase.

17 Mar 2010

Schiff Nutrition International third-quarter net sales increase to 53.3M

Schiff Nutrition International, Inc., today announced results for the fiscal 2010 third quarter and nine months ended February 28, 2010. The company also announced plans to return $0.50 per share to shareholders through a special cash dividend payable on April 14, 2010 to shareholders of record at the close of business on March 31, 2010.

17 Mar 2010

Protalix BioTherapeutics commences clinical trial of human acetylcholinesterase for biodefense indications

Protalix BioTherapeutics, Inc. announced today that it has initiated a phase I clinical trial of PRX-105, the Company's plant cell expressed pegylated recombinant human acetylcholinesterase product candidate in development for biodefense indications. The trial is designed to study the safety of PRX-105 by administering a bolus intravenous injection of PRX-105 in healthy volunteers.

17 Mar 2010

New chemotherapy agents improve survival time for patients with metastatic colorectal cancer

New chemotherapy agents appear associated with improvements in survival time for patients with metastatic colorectal cancer but at substantial cost.

17 Mar 2010

Human Genome Sciences announces Phase 2 results of mapatumumab combination therapy for NSCLC

Human Genome Sciences, Inc. today announced the results of its randomized Phase 2 trial of mapatumumab (HGS-ETR1) in combination with the chemotherapy agents paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancer (NSCLC).

17 Mar 2010

Palomar SlimLipo body sculpting laser to be featured on The Dr. Oz Show

Palomar Medical Technologies, Inc., a leading researcher and developer of lasers and pulsed-light systems for aesthetic treatments, is pleased to announce that the Palomar SlimLipo body sculpting laser will be featured on The Dr. Oz Show on Wednesday, March 17.

17 Mar 2010

AHF’s Magic Johnson ‘Testing America’ Tour arrives in Nashville to offer free HIV testing

AHF’s Magic Johnson ‘Testing America’ Tour, a six month, 48 state national cross country HIV testing tour, arrives in Nashville, Tennessee and will offer free HIV testing, along with local partner Street Works at events today and tomorrow.

17 Mar 2010

Stomach wrap operations more effective than acid suppression tablets in severe acid reflux treatment

Stomach wrap operations may be more effective than acid suppression tablets in the treatment of severe acid reflux, according to a new Cochrane Systematic Review. The study shows a more pronounced improvement in symptoms shortly after surgery than with drug treatment.

17 Mar 2010

Greatbatch Medical's OptiSeal Valved PTFE Peelable Introducer receives 510(k) clearance

Greatbatch Medical announced today that it has received regulatory clearance for its next generation valved peelable introducer used in the delivery of leads and catheters into the venous system. OptiSeal™ Valved PTFE Peelable Introducer achieved regulatory clearance on Monday, March 15, 2010, representing the first 510(k) regulatory approval under the Greatbatch Medical brand. It is also approved in Canada and CE marked for distribution in Europe.

17 Mar 2010

First Edition: March 17, 2010

Today's news continues to focus on Democratic leaders' efforts to finalize their health reform package and gather the votes necessary to gain House passage.

17 Mar 2010

Liver cancer: Treatment with intra-arterial yttrium-90 microspheres promising

An interventional radiology treatment-the use of intra-arterial yttrium-90 microspheres for liver cancer (also known as hepatocellular carcinoma)-shows promise in prolonging life for many patients with this devastating condition, according to researchers at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa, Fla.

17 Mar 2010

Researchers develop new analytical method to process large amounts of information faster

Researchers at North Carolina State University have developed a new analytical method that opens the door to faster processing of large amounts of information, with applications in fields as diverse as the military, medical diagnostics and homeland security.

17 Mar 2010

PAREXEL genotypes over 10,000 potential study participants to identify 400 CYP2D6 poor metabolizers

PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced that it has completed a large and complex pharmacogenetics-based early phase study. The study was conducted in a healthy volunteer population of poor metabolizers of Cytochrome P450 2D6 (CYP2D6), an important enzyme involved in the metabolism of drugs. The study monitored the QTc interval following administration of a neurological treatment, which has been shown to have a higher drug exposure in poor metabolizers of CYP2D6.

From Parexel 17 Mar 2010

Medical News

Meridian Bioscience revises fiscal 2010 guidance, expects net sales between $145M and $153M

SBRT may improve survival rates for lung-cancer patients: Study

China Sky One Medical's 2009 fourth-quarter total revenues up 15.0%

IRIS International announces the launch of new and improved corporate website

StockPreacher.com: ACAD reports net loss of $8.7M for fourth-quarter of 2009

Full Medicare coverage for IVF: CFAS felicitates Quebec government

Renhuang Pharmaceuticals' net income for first-quarter of 2010 increases 17.8%

Research confirms benefits of PET scan in early detection of Alzheimer's disease

Schiff Nutrition International third-quarter net sales increase to 53.3M

Protalix BioTherapeutics commences clinical trial of human acetylcholinesterase for biodefense indications

New chemotherapy agents improve survival time for patients with metastatic colorectal cancer

Human Genome Sciences announces Phase 2 results of mapatumumab combination therapy for NSCLC

Palomar SlimLipo body sculpting laser to be featured on The Dr. Oz Show

AHF’s Magic Johnson ‘Testing America’ Tour arrives in Nashville to offer free HIV testing

Stomach wrap operations more effective than acid suppression tablets in severe acid reflux treatment

Greatbatch Medical's OptiSeal Valved PTFE Peelable Introducer receives 510(k) clearance

First Edition: March 17, 2010

Liver cancer: Treatment with intra-arterial yttrium-90 microspheres promising

Researchers develop new analytical method to process large amounts of information faster

PAREXEL genotypes over 10,000 potential study participants to identify 400 CYP2D6 poor metabolizers

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Modular cleanrooms: Enhancing flexibility and compliance

Latest News